1887

Abstract

Central venous catheter (CVC)-related infections are a major problem for patients requiring long-term venous access and may result in frequent hospital admissions and difficulties in maintaining central venous access. CVC-related blood stream infections are associated with increased duration of inpatient stay and cost approximately \#8364;13 585 per patient [Blot, S. I., Depuydt, P., Annemans, L., Benoit, D., Hoste, E., De Waele, J. J., Decruyenaere, J., Vogelaers, D., Colardyn, F. & Vandewoude, K. H. (2005). , 1591–1598]. Antimicrobial lock therapy may prevent CVC-related blood stream infection, preserve central venous access and reduce hospital admissions. In this paper, the impact of linezolid lock prophylaxis in a patient with short bowel syndrome is described.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.47665-0
2008-04-01
2019-11-12
Loading full text...

Full text loading...

/deliver/fulltext/jmm/57/4/534.html?itemId=/content/journal/jmm/10.1099/jmm.0.47665-0&mimeType=html&fmt=ahah

References

  1. Carratala, J., Niubo, J., Fernandez-Sevilla, A., Juve, E., Castellsague, X., Berlanga, J., Linares, J. & Gudiol, F. ( 1999; ). Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer. Antimicrob Agents Chemother 43, 2200–2204.
    [Google Scholar]
  2. Castagnola, E., Moroni, C., Gandullia, P., Oddone, M., Peri, C., Casciaro, R. & De Alessandri, A. ( 2006; ). Catheter lock and systemic infusion of linezolid for treatment of persistent Broviac catheter-related staphylococcal bacteremia. Antimicrob Agents Chemother 50, 1120–1121.[CrossRef]
    [Google Scholar]
  3. Centers for Disease Control and Prevention ( 2005; ). Reduction in central line-associated bloodstream infections among patients in intensive care units – Pennsylvania, April 2001–March 2005. MMWR Morb Mortal Wkly Rep 54, 1013–1016.
    [Google Scholar]
  4. Cha, R., Brown, W. J. & Rybak, M. J. ( 2003; ). Bactericidal activities of daptomycin, quinupristin-dalfopristin, and linezolid against vancomycin-resistant Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations. Antimicrob Agents Chemother 47, 3960–3963.[CrossRef]
    [Google Scholar]
  5. Curtin, J., Cormican, M., Fleming, G., Keelehan, J. & Colleran, E. ( 2003; ). Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections. Antimicrob Agents Chemother 47, 3145–3148.[CrossRef]
    [Google Scholar]
  6. Garland, J. S., Alex, C. P., Henrickson, K. J., McAuliffe, T. L. & Maki, D. G. ( 2005; ). A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial. Pediatrics 116, e198–e205.[CrossRef]
    [Google Scholar]
  7. LaPlante, K. L. & Mermel, L. A. ( 2007; ). In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model. Nephrol Dial Transplant 22, 2239–2246.[CrossRef]
    [Google Scholar]
  8. Mermel, L. A., Farr, B. M., Sherertz, R. J., Raad, I. I., O'Grady, N., Harris, J. S. & Craven, D. E. ( 2001; ). Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 32, 1249–1272.[CrossRef]
    [Google Scholar]
  9. O'Grady, N. P., Alexander, M., Dellinger, E. P., Gerberding, J. L., Heard, S. O., Maki, D. G., Masur, H., McCormick, R. D., Mermel, L. A. & other authors ( 2002; ). Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 35, 1281–1307.[CrossRef]
    [Google Scholar]
  10. Onder, A. M., Kato, T., Simon, N., Rivera-Hernandez, M., Chandar, J., Montane, B., Francoeur, D., Salvaggi, G., Tzakis, A. G. & Zilleruelo, G. ( 2007; ). Prevention of catheter-related bacteremia in pediatric intestinal transplantation/short gut syndrome children with long-term central venous catheters. Pediatr Transplant 11, 87–93.[CrossRef]
    [Google Scholar]
  11. Pronovost, P., Needham, D., Berenholtz, S., Sinopoli, D., Chu, H., Cosgrove, S., Sexton, B., Hyzy, R., Welsh, R. & other authors ( 2006; ). An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 355, 2725–2732.[CrossRef]
    [Google Scholar]
  12. Raad, I., Hanna, H., Jiang, Y., Dvorak, T., Reitzel, R., Chaiban, G., Sherertz, R. & Hachem, R. ( 2007; ). Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Chemother 51, 1656–1660.[CrossRef]
    [Google Scholar]
  13. Safdar, N. & Maki, D. G. ( 2006; ). Use of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: a meta-analysis of prospective, randomized trials. Clin Infect Dis 43, 474–484.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.47665-0
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error